High dose of red wine elicits enhanced inhibition of fibrinolysis

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):161-3. doi: 10.1097/HJR.0b013e328320ad1b.

Abstract

Background and design: The purpose of this randomized controlled cross-over study was to determine the acute effects of high doses of alcoholic beverages on circulating markers related to atherosclerosis and fibrinolysis.

Methods: Twenty-two healthy men consumed a high dose (8.1+/-0.9 dl) of alcohol-containing red wine and dealcoholized red wine, and an equal ethanol dose of cognac (2.4+/-0.3 dl). Blood samples were taken before and shortly after interventions.

Results: Red wine, unlike dealcoholized red wine and cognac, increased tissue plasminogen activator inhibitor-1 levels significantly, indicating an acute inhibition of fibrinolysis after a high dose.

Conclusion: Findings may explain the increased risk of cardiovascular mortality among binge drinkers.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / adverse effects*
  • Alcohol Drinking / blood
  • Atherosclerosis / blood
  • Atherosclerosis / etiology*
  • Biomarkers / blood
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Cross-Over Studies
  • Ethanol / adverse effects*
  • Ethanol / blood
  • Fibrinolysis / drug effects*
  • Humans
  • Inflammation Mediators / blood
  • Male
  • Plasminogen Activator Inhibitor 1 / blood
  • Wine / adverse effects*
  • Young Adult

Substances

  • Biomarkers
  • Inflammation Mediators
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • Ethanol